Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional citrate anticoagulation versus heparin-free hemodialysis in maintenance hemodialysis patients at high bleeding risk
ChiCTR1900027425Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trisodium citrate in kidney failure (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Filter and venous trap clotting. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
trisodium citrate
03
Conditions
kidney failure
Beyond the preview
Go deeper on ChiCTR1900027425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027425.